# Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

> **NCT06323447** · — · NOT_YET_RECRUITING · sponsor: **Leuko Labs, Inc.** · enrollment: 210 (estimated)

## Conditions studied

- Diffuse Large B Cell Lymphoma
- Multiple Myeloma

## Interventions

- **DIAGNOSTIC_TEST:** PointCheck

## Key facts

- **NCT ID:** NCT06323447
- **Lead sponsor:** Leuko Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-04-28
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06323447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06323447, "Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06323447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*